PubRank

Donald E Low

Author PubWeight™ 259.80‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Identification of severe acute respiratory syndrome in Canada. N Engl J Med 2003 14.29
2 Outpatient gatifloxacin therapy and dysglycemia in older adults. N Engl J Med 2006 7.01
3 Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia. N Engl J Med 2002 6.22
4 Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis 2007 5.39
5 Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada. JAMA 2013 4.69
6 An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections. Nat Med 2002 3.39
7 Empirical validation of guidelines for the management of pharyngitis in children and adults. JAMA 2004 3.14
8 Triple reassortant H3N2 influenza A viruses, Canada, 2005. Emerg Infect Dis 2006 3.05
9 West Nile virus infection in 2002: morbidity and mortality among patients admitted to hospital in southcentral Ontario. CMAJ 2003 3.03
10 At the threshold: defining clinically meaningful resistance thresholds for antibiotic choice in community-acquired pneumonia. Clin Infect Dis 2008 2.71
11 Evolutionary pathway to increased virulence and epidemic group A Streptococcus disease derived from 3,615 genome sequences. Proc Natl Acad Sci U S A 2014 2.63
12 Predicting antimicrobial resistance in invasive pneumococcal infections. Clin Infect Dis 2005 2.59
13 Molecular complexity of successive bacterial epidemics deconvoluted by comparative pathogenomics. Proc Natl Acad Sci U S A 2010 2.43
14 Managing skin and soft tissue infections: expert panel recommendations on key decision points. J Antimicrob Chemother 2003 2.41
15 Genome-wide molecular dissection of serotype M3 group A Streptococcus strains causing two epidemics of invasive infections. Proc Natl Acad Sci U S A 2004 2.32
16 Genetic variability of human respiratory syncytial virus A strains circulating in Ontario: a novel genotype with a 72 nucleotide G gene duplication. PLoS One 2012 2.21
17 Detection of airborne severe acute respiratory syndrome (SARS) coronavirus and environmental contamination in SARS outbreak units. J Infect Dis 2005 2.03
18 Invasive M1T1 group A Streptococcus undergoes a phase-shift in vivo to prevent proteolytic degradation of multiple virulence factors by SpeB. Mol Microbiol 2004 1.99
19 Outcomes assessment of the surgical management of esophageal cancer in younger and older patients. Ann Thorac Surg 2012 1.96
20 Severe group a streptococcal soft-tissue infections in Ontario: 1992-1996. Clin Infect Dis 2002 1.93
21 Mosaic prophages with horizontally acquired genes account for the emergence and diversification of the globally disseminated M1T1 clone of Streptococcus pyogenes. J Bacteriol 2005 1.90
22 New Delhi metallo-beta-lactamase, Ontario, Canada. Emerg Infect Dis 2011 1.81
23 Phylogenetic analysis reveals a cryptic species Blastomyces gilchristii, sp. nov. within the human pathogenic fungus Blastomyces dermatitidis. PLoS One 2013 1.79
24 Integrated analysis of FOCUS 1 and FOCUS 2: randomized, doubled-blinded, multicenter phase 3 trials of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in patients with community-acquired pneumonia. Clin Infect Dis 2010 1.78
25 Successful management of severe group A streptococcal soft tissue infections using an aggressive medical regimen including intravenous polyspecific immunoglobulin together with a conservative surgical approach. Scand J Infect Dis 2005 1.75
26 Clostridium difficile infection in hospitals: a brewing storm. CMAJ 2004 1.74
27 New Delhi metallo-β-lactamase-1: local acquisition in Ontario, Canada, and challenges in detection. CMAJ 2011 1.73
28 Modulation of bacterial growth by tumor necrosis factor-alpha in vitro and in vivo. Am J Respir Crit Care Med 2003 1.70
29 Treatment of Barrett's esophagus with early neoplasia: a comparison of endoscopic therapy and esophagectomy. Gastrointest Endosc 2008 1.69
30 Clinical and epidemiologic features of group a streptococcal pneumonia in Ontario, Canada. Arch Intern Med 2003 1.67
31 FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia. J Antimicrob Chemother 2011 1.66
32 Risk factors for resistance to antimicrobial agents among nursing home residents. Am J Epidemiol 2003 1.62
33 Canadian guidelines for the management of acute exacerbations of chronic bronchitis: executive summary. Can Respir J 2003 1.58
34 Volume-outcome relationship in surgery for esophageal malignancy: systematic review and meta-analysis 2000-2011. J Gastrointest Surg 2011 1.57
35 The society of thoracic surgeons guidelines on the diagnosis and staging of patients with esophageal cancer. Ann Thorac Surg 2013 1.56
36 Severe acute respiratory syndrome (SARS): a year in review. Annu Rev Med 2005 1.55
37 Identification of a streptolysin S-associated gene cluster and its role in the pathogenesis of Streptococcus iniae disease. Infect Immun 2002 1.52
38 Interpretation of diagnostic laboratory tests for severe acute respiratory syndrome: the Toronto experience. CMAJ 2004 1.50
39 A review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance. Clin Infect Dis 2005 1.49
40 Proton pump inhibitors and hospitalization for Clostridium difficile-associated disease: a population-based study. Clin Infect Dis 2006 1.48
41 Genome-wide dissection of globally emergent multi-drug resistant serotype 19A Streptococcus pneumoniae. BMC Genomics 2009 1.47
42 Decreased necrotizing fasciitis capacity caused by a single nucleotide mutation that alters a multiple gene virulence axis. Proc Natl Acad Sci U S A 2010 1.47
43 Methicillin-resistant Staphylococcus aureus colonization in veterinary personnel. Emerg Infect Dis 2006 1.46
44 Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada. Antimicrob Agents Chemother 2010 1.45
45 Possible SARS coronavirus transmission during cardiopulmonary resuscitation. Emerg Infect Dis 2004 1.45
46 Viable group A streptococci in macrophages during acute soft tissue infection. PLoS Med 2006 1.43
47 Pulmonary pathology of severe acute respiratory syndrome in Toronto. Mod Pathol 2005 1.41
48 Distinct signatures of diversifying selection revealed by genome analysis of respiratory tract and invasive bacterial populations. Proc Natl Acad Sci U S A 2011 1.39
49 Community-associated methicillin-resistant Staphylococcus aureus in horses and humans who work with horses. J Am Vet Med Assoc 2005 1.37
50 Is surveillance for multidrug-resistant enterobacteriaceae an effective infection control strategy in the absence of an outbreak? J Infect Dis 2002 1.37
51 Toward an understanding of changes in diversity associated with fecal microbiome transplantation based on 16S rRNA gene deep sequencing. MBio 2012 1.36
52 Outbreak of carbapenem-resistant enterobacteriaceae containing blaNDM-1, Ontario, Canada. Clin Infect Dis 2012 1.36
53 New Delhi metallo-β-lactamase-1 in Enterobacteriaceae: emerging resistance. CMAJ 2011 1.33
54 Full-genome dissection of an epidemic of severe invasive disease caused by a hypervirulent, recently emerged clone of group A Streptococcus. Am J Pathol 2012 1.32
55 Group A Streptococcus emm gene types in pharyngeal isolates, Ontario, Canada, 2002-2010. Emerg Infect Dis 2011 1.32
56 In vitro antimicrobial susceptibilities of Streptococcus pneumoniae clinical isolates obtained in Canada in 2002. Antimicrob Agents Chemother 2004 1.30
57 The impact of empirical management of acute cystitis on unnecessary antibiotic use. Arch Intern Med 2002 1.29
58 Antimicrobial susceptibility breakpoints and first-step parC mutations in Streptococcus pneumoniae: redefining fluoroquinolone resistance. Emerg Infect Dis 2003 1.28
59 rmtD2, a new allele of a 16S rRNA methylase gene, has been present in Enterobacteriaceae isolates from Argentina for more than a decade. Antimicrob Agents Chemother 2010 1.23
60 Severe acute respiratory syndrome. Clin Infect Dis 2004 1.23
61 Multiplex PCR tests sentinel the appearance of pandemic influenza viruses including H1N1 swine influenza. J Clin Virol 2009 1.23
62 Detection and species identification of Leishmania DNA from filter paper lesion impressions for patients with American cutaneous leishmaniasis. Clin Infect Dis 2010 1.22
63 Comparative evaluation of a chromogenic agar medium, the modified Hodge test, and a battery of meropenem-inhibitor discs for detection of carbapenemase activity in Enterobacteriaceae. J Clin Microbiol 2011 1.21
64 Cathelicidin LL-37 in severe Streptococcus pyogenes soft tissue infections in humans. Infect Immun 2008 1.21
65 Antimicrobial susceptibility among organisms from the Asia/Pacific Rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline. J Antimicrob Chemother 2007 1.20
66 Outbreak of vancomycin-susceptible Enterococcus faecium containing the wild-type vanA gene. J Clin Microbiol 2014 1.20
67 Antimicrobial susceptibility of 15,644 pathogens from Canadian hospitals: results of the CANWARD 2007-2009 study. Diagn Microbiol Infect Dis 2011 1.20
68 Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus. J Infect Dis 2004 1.18
69 Severe acute respiratory syndrome-associated coronavirus in lung tissue. Emerg Infect Dis 2004 1.16
70 Characterization of an influenza A and influenza B co-infection of a patient in a long-term care facility with co-circulating influenza A and influenza B. Int J Infect Dis 2008 1.14
71 Postgenomic analysis of four novel antigens of group a streptococcus: growth phase-dependent gene transcription and human serologic response. J Bacteriol 2002 1.14
72 Getting under the skin: the immunopathogenesis of Streptococcus pyogenes deep tissue infections. Clin Infect Dis 2010 1.13
73 MupB, a new high-level mupirocin resistance mechanism in Staphylococcus aureus. Antimicrob Agents Chemother 2012 1.13
74 Evaluation and verification of the Seeplex Diarrhea-V ACE assay for simultaneous detection of adenovirus, rotavirus, and norovirus genogroups I and II in clinical stool specimens. J Clin Microbiol 2011 1.11
75 Use of self-expandable metallic stents in benign GI diseases. Gastrointest Endosc 2003 1.11
76 Canadian guidelines for the management of acute exacerbations of chronic bronchitis. Can Respir J 2003 1.11
77 Necrotizing pneumonia and septic shock: suspecting CA-MRSA in patients presenting to Canadian emergency departments. CJEM 2007 1.10
78 Effect on antibiotic prescribing of repeated clinical prompts to use a sore throat score: lessons from a failed community intervention study. J Fam Pract 2002 1.08
79 Evolving management strategies in esophageal perforation: surgeons using nonoperative techniques to improve outcomes. J Am Coll Surg 2011 1.07
80 Evaluation of a microculture method for isolation of Leishmania parasites from cutaneous lesions of patients in Peru. J Clin Microbiol 2007 1.07
81 Phylogenetic incongruence in E. coli O104: understanding the evolutionary relationships of emerging pathogens in the face of homologous recombination. PLoS One 2012 1.06
82 Outcomes and health-related quality of life after esophagectomy for high-grade dysplasia and intramucosal cancer. Arch Surg 2006 1.06
83 Treatment of acute bacterial conjunctivitis: 1% fusidic acid viscous drops vs. 0.3% tobramycin drops. Can J Ophthalmol 2002 1.06
84 Epidemic of group A Streptococcus M/emm59 causing invasive disease in Canada. Clin Infect Dis 2010 1.06
85 Extensive genomic variation within clonal complexes of Neisseria meningitidis. Genome Biol Evol 2011 1.06
86 Laboratory diagnosis of amoebic keratitis: comparison of four diagnostic methods for different types of clinical specimens. J Clin Microbiol 2009 1.06
87 Complete sequence of pOZ176, a 500-kilobase IncP-2 plasmid encoding IMP-9-mediated carbapenem resistance, from outbreak isolate Pseudomonas aeruginosa 96. Antimicrob Agents Chemother 2013 1.05
88 New endemic Legionella pneumophila serogroup I clones, Ontario, Canada. Emerg Infect Dis 2010 1.05
89 Distribution of antiseptic resistance genes qacA, qacB, and smr in methicillin-resistant Staphylococcus aureus isolated in Toronto, Canada, from 2005 to 2009. Antimicrob Agents Chemother 2011 1.05
90 Advances in the management of esophageal perforation. Thorac Surg Clin 2011 1.05
91 The battle against emerging antibiotic resistance: should fluoroquinolones be used to treat children? Clin Infect Dis 2002 1.04
92 Emergence of macrolide resistance in throat culture isolates of group a streptococci in Ontario, Canada, in 2001. Antimicrob Agents Chemother 2003 1.04
93 Can routine laboratory tests discriminate between severe acute respiratory syndrome and other causes of community-acquired pneumonia? Clin Infect Dis 2005 1.04
94 Polymorphisms in regulator of protease B (RopB) alter disease phenotype and strain virulence of serotype M3 group A Streptococcus. J Infect Dis 2012 1.02
95 Rhinovirus outbreaks in long-term care facilities, Ontario, Canada. Emerg Infect Dis 2010 1.02
96 Novel mutations in a patient isolate of Streptococcus agalactiae with reduced penicillin susceptibility emerging after long-term oral suppressive therapy. Antimicrob Agents Chemother 2011 1.02
97 Diagnostic performance of filter paper lesion impression PCR for secondarily infected ulcers and nonulcerative lesions caused by cutaneous leishmaniasis. J Clin Microbiol 2010 1.01
98 Physiology, not chronology, dictates outcomes after esophagectomy for esophageal cancer: outcomes in patients 80 years and older. Ann Surg Oncol 2012 1.00
99 Combining clinical and epidemiologic features for early recognition of SARS. Emerg Infect Dis 2004 1.00
100 Analytical and clinical validation of novel real-time reverse transcriptase-polymerase chain reaction assays for the clinical detection of swine-origin H1N1 influenza viruses. Diagn Microbiol Infect Dis 2011 1.00
101 Vancomycin-variable Enterococcus faecium: in vivo emergence of vancomycin resistance in a vancomycin-susceptible isolate. J Clin Microbiol 2014 1.00
102 Accordion severity grading system: assessment of relationship between costs, length of hospital stay, and survival in patients with complications after esophagectomy for cancer. J Am Coll Surg 2012 0.99
103 Characterization of invasive group B streptococcus strains from the greater Toronto area, Canada. J Clin Microbiol 2014 0.99
104 Surveillance for hospital outbreaks of invasive group a streptococcal infections in Ontario, Canada, 1992 to 2000. Ann Intern Med 2007 0.99
105 The impact of influenza on the Canadian First Nations. Can J Public Health 2011 0.99
106 Macrolide-resistant Mycoplasma pneumoniae in humans, Ontario, Canada, 2010-2011. Emerg Infect Dis 2013 0.98
107 Assessment of short-term clinical outcomes following salvage esophagectomy for the treatment of esophageal malignancy: systematic review and pooled analysis. Ann Surg Oncol 2013 0.98
108 Near-total esophagectomy: the influence of standardized multimodal management and intraoperative fluid restriction. Reg Anesth Pain Med 2003 0.97
109 Morbidity and mortality of patients with invasive group A streptococcal infections admitted to the ICU. Chest 2006 0.97
110 Going with the flow: legionellosis risk in Toronto, Canada is strongly associated with local watershed hydrology. Ecohealth 2009 0.97
111 Comparative Genomics Reveal That Host-Innate Immune Responses Influence the Clinical Prevalence of Legionella pneumophila Serogroups. PLoS One 2013 0.97
112 Is primary prevention of Clostridium difficile infection possible with specific probiotics? Int J Infect Dis 2012 0.97
113 Type II topoisomerase mutations in Bacillus anthracis associated with high-level fluoroquinolone resistance. J Antimicrob Chemother 2004 0.97
114 Screening for asymptomatic bacteriuria in pregnancy. J Obstet Gynaecol Can 2005 0.96
115 Community-acquired antibiotic resistance in urinary isolates from adult women in Canada. Can J Infect Dis Med Microbiol 2006 0.96
116 Useful benchmarks to evaluate outcomes after esophagectomy and pancreaticoduodenectomy. Am J Surg 2004 0.96
117 Severe human rhinovirus outbreak associated with fatalities in a long-term care facility in Ontario, Canada. J Am Geriatr Soc 2010 0.96
118 Launching of the CAN-R Web site -The official Web site of the Canadian Antimicrobial Resistance Alliance. Can J Infect Dis Med Microbiol 2007 0.95
119 Homologous recombination drives both sequence diversity and gene content variation in Neisseria meningitidis. Genome Biol Evol 2013 0.95
120 Optimization of microculture and evaluation of miniculture for the isolation of Leishmania parasites from cutaneous lesions in Peru. Am J Trop Med Hyg 2008 0.95
121 Multidrug-resistant pandemic (H1N1) 2009 infection in immunocompetent child. Emerg Infect Dis 2011 0.94
122 Susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Antimicrob Agents Chemother 2011 0.94
123 Biofilms: the stronghold of Legionella pneumophila. Int J Mol Sci 2013 0.93
124 Pertussis resurgence in Toronto, Canada: a population-based study including test-incidence feedback modeling. BMC Public Health 2011 0.93
125 Whole-genome sequence of Streptococcus pseudopneumoniae isolate IS7493. J Bacteriol 2011 0.93
126 Pneumococcal vaccination programs and the burden of invasive pneumococcal disease in Ontario, Canada, 1995-2011. Vaccine 2013 0.91
127 Trends in antibiotic resistance over time among pathogens from Canadian hospitals: results of the CANWARD study 2007-11. J Antimicrob Chemother 2013 0.91
128 Clinical and demographic stratification of test performance: a pooled analysis of five laboratory diagnostic methods for American cutaneous leishmaniasis. Am J Trop Med Hyg 2010 0.90
129 Non-invasive cytology brush PCR diagnostic testing in mucosal leishmaniasis: superior performance to conventional biopsy with histopathology. PLoS One 2011 0.90
130 Repair of giant paraesophageal hernias routinely produces improvement in respiratory function. J Thorac Cardiovasc Surg 2011 0.90
131 Streptococcus pneumoniae infection: a Canadian perspective. Expert Rev Anti Infect Ther 2013 0.90
132 Modified multiple-locus variable-number tandem-repeat analysis for rapid identification and typing of Clostridium difficile during institutional outbreaks. J Clin Microbiol 2011 0.90
133 Laboratory-based evaluation of legionellosis epidemiology in Ontario, Canada, 1978 to 2006. BMC Infect Dis 2009 0.89
134 Gastric ulceration following oesophageal stent migration complicating surgical management of oesophageal cancer. Interact Cardiovasc Thorac Surg 2012 0.89
135 Assessment of criteria and clinical significance of circumferential resection margins in esophageal cancer. Arch Surg 2009 0.89
136 Systemic dysregulation of angiopoietin-1/2 in streptococcal toxic shock syndrome. Clin Infect Dis 2011 0.88
137 Treatment of community-acquired pneumonia. CMAJ 2008 0.88
138 Spontaneous intramural rupture of the esophagus: clinical presentation and endoscopic findings. Gastrointest Endosc 2002 0.88
139 High-level telithromycin resistance in a clinical isolate of Streptococcus pneumoniae. Antimicrob Agents Chemother 2007 0.88
140 Treatment and vaccines for severe acute respiratory syndrome. Lancet Infect Dis 2005 0.88
141 The clinical and economic costs of delirium after surgical resection for esophageal malignancy. Ann Surg 2013 0.88
142 Clinical ramifications of giant paraesophageal hernias are underappreciated: making the case for routine surgical repair. Ann Thorac Surg 2012 0.87
143 Surveillance data on outbreaks of Clostridium difficile infection in Ontario, Canada, in 2008-2009. Clin Infect Dis 2010 0.87
144 Is resistance futile? Nat Med 2003 0.87
145 Evaluation of CLSI agar dilution method and Trek Sensititre broth microdilution panel for determining antimicrobial susceptibility of Streptococcus pneumoniae. J Clin Microbiol 2010 0.87
146 Is It Time to Centralize High-risk Cancer Care in the United States? Comparison of Outcomes of Esophagectomy Between England and the United States. Ann Surg 2015 0.86
147 In vitro activity of ceftaroline, ceftobiprole and cethromycin against clinical isolates of Streptococcus pneumoniae collected from across Canada between 2003 and 2008. J Antimicrob Chemother 2009 0.86
148 Legionella infections and travel associated legionellosis. Travel Med Infect Dis 2010 0.86
149 Genetic characterization of seasonal influenza A (H3N2) viruses in Ontario during 2010-2011 influenza season: high prevalence of mutations at antigenic sites. Influenza Other Respir Viruses 2013 0.86
150 Assessment of intra-operative haemodynamic changes associated with transhiatal and transthoracic oesophagectomy. Eur J Cardiothorac Surg 2010 0.86
151 Escherichia coli O104:H4 infections and international travel. Emerg Infect Dis 2012 0.86
152 Lcl of Legionella pneumophila is an immunogenic GAG binding adhesin that promotes interactions with lung epithelial cells and plays a crucial role in biofilm formation. Infect Immun 2011 0.86
153 Characterization of the quinolone resistant determining regions in clinical isolates of pneumococci collected in Canada. Ann Clin Microbiol Antimicrob 2010 0.86
154 Emergence of levofloxacin-resistant pneumococci in immunocompromised adults after therapy for community-acquired pneumonia. Clin Infect Dis 2003 0.86
155 Respiratory infection in institutions during early stages of pandemic (H1N1) 2009, Canada. Emerg Infect Dis 2009 0.86
156 The impact of neoadjuvant chemoradiotherapy on perioperative outcomes, tumor pathology, and survival in clinical stage II and III esophageal cancer. Ann Surg Oncol 2013 0.85
157 Clinical aspects and cost of invasive Streptococcus pneumoniae infections in children: resistant vs. susceptible strains. Int J Antimicrob Agents 2002 0.85
158 Respiratory illnesses in Canadian health care workers: a pilot study of influenza vaccine and oseltamivir prophylaxis during the 2007/2008 influenza season. Influenza Other Respir Viruses 2011 0.85
159 Prevalence and characterization of invasive isolates of Streptococcus pyogenes with reduced susceptibility to fluoroquinolones. Antimicrob Agents Chemother 2005 0.85
160 Use of the Vitek-1 and Vitek-2 systems for detection of constitutive and inducible macrolide resistance in group B streptococci. J Clin Microbiol 2004 0.84
161 Ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections. Drugs 2012 0.84
162 Activities of new fluoroquinolones, ketolides, and other antimicrobials against blood culture isolates of viridans group streptococci from across Canada, 2000. Antimicrob Agents Chemother 2002 0.83
163 Carbapenem resistance in Canada. CMAJ 2009 0.83
164 Polymerase chain reaction detection of Leishmania kDNA from the urine of Peruvian patients with cutaneous and mucocutaneous leishmaniasis. Am J Trop Med Hyg 2011 0.82
165 Use of the Seeplex RV Detection kit for surveillance of respiratory viral outbreaks in Toronto, Ontario, Canada. Ann Clin Lab Sci 2008 0.82
166 In an era of health reform: defining cost differences in current esophageal cancer management strategies and assessing the cost of complications. J Thorac Cardiovasc Surg 2010 0.81
167 Annual macrolide prescription rates and the emergence of macrolide resistance among Streptococcus pneumoniae in Canada from 1995 to 2005. Int J Antimicrob Agents 2009 0.81
168 High prevalence of asymptomatic bocavirus in daycare: is otitis media a confounder? J Infect Dis 2010 0.81
169 Respiratory viral infections in institutions from late stage of the first and second waves of pandemic influenza A (H1N1) 2009, Ontario, Canada. Influenza Other Respir Viruses 2012 0.81
170 Investigation of Staphylococcus aureus isolates identified as erythromycin intermediate by the Vitek-1 System: comparison with results obtained with the Vitek-2 and Phoenix systems. J Clin Microbiol 2003 0.81
171 Mechanism of invasion of lung epithelial cells by filamentous Legionella pneumophila. Cell Microbiol 2012 0.81
172 Comparative Genomic Analyses of Streptococcus pseudopneumoniae Provide Insight into Virulence and Commensalism Dynamics. PLoS One 2013 0.81
173 Potential T cell epitopes within swine-origin triple reassortant influenza A (H3N2) variant virus which emerged in 2011: an immunoinformatics study. Vaccine 2012 0.80
174 Fluoroquinolones for treatment of community-acquired pneumonia and tuberculosis: putting the risk of resistance into perspective. Clin Infect Dis 2009 0.80
175 Non-invasive cytology brush PCR for the diagnosis and causative species identification of American cutaneous leishmaniasis in Peru. PLoS One 2012 0.80
176 Fluoroquinolone-resistant pneumococci: maybe resistance isn't futile? Clin Infect Dis 2004 0.80
177 A standardized anesthetic and surgical clinical pathway for esophageal resection: impact on length of stay and major outcomes. Reg Anesth Pain Med 2015 0.80
178 The Legionella pneumophila collagen-like protein mediates sedimentation, autoaggregation, and pathogen-phagocyte interactions. Appl Environ Microbiol 2013 0.79
179 A comparison of bacteremic pneumococcal pneumonia with nonbacteremic community-acquired pneumonia of any etiology--results from a Canadian multicentre study. Can Respir J 2003 0.79
180 Essential roles and regulation of the Legionella pneumophila collagen-like adhesin during biofilm formation. PLoS One 2012 0.79
181 Evolution of standardized clinical pathways: refining multidisciplinary care and process to improve outcomes of the surgical treatment of esophageal cancer. J Gastrointest Surg 2014 0.79
182 Utility of the BD Directigen Flu A+B rapid antigen detection assay as an influenza outbreak detection tool. Int J Infect Dis 2009 0.79
183 Assessing the impact of intravenous immunoglobulin in the management of streptococcal toxic shock syndrome: a noble but difficult quest. Clin Infect Dis 2009 0.79
184 A new twist on an old problem. A case of pediatric meningitis caused by multidrug-resistant Streptococcus pneumoniae serotype 19 A. Pediatr Infect Dis J 2009 0.78
185 Resistance to antibiotics: administrative response to the challenge. Manag Care Interface 2004 0.78
186 Recovery of influenza B virus with the H273Y point mutation in the neuraminidase active site from a human patient. J Clin Microbiol 2012 0.78
187 Late recognition of SARS in nosocomial outbreak, Toronto. Emerg Infect Dis 2005 0.78
188 Decentralized molecular diagnostic testing plan for pandemic influenza in the Ontario Public Health Laboratory system. Can J Public Health 2008 0.78
189 Respiratory virus panels for global surveillance of emerging infectious diseases. J Clin Virol 2007 0.78
190 Genetic analysis of invasive pneumococcal isolates from children in Ontario, Canada, 2007-2012. Pediatr Infect Dis J 2015 0.77
191 Proteomics and severe acute respiratory syndrome (SARS): emerging technology meets emerging pathogen. Clin Chem 2005 0.77
192 Iron-deficiency anemia is a common presenting issue with giant paraesophageal hernia and resolves following repair. J Gastrointest Surg 2013 0.77
193 Novel multimodality endoscopic closure of postoperative esophageal fistula. Int J Surg Case Rep 2012 0.77
194 Genomic analysis of Pseudomonas aeruginosa PA96, the host of carbapenem resistance plasmid pOZ176. FEMS Microbiol Lett 2014 0.76
195 Correction: Phylogenetic Analysis Reveals a Cryptic Species Blastomyces gilchristii, sp. nov. within the Human Pathogenic Fungus Blastomyces dermatitidis. PLoS One 2016 0.75
196 Verona integron-encoded metallo-β-lactamase 1 in Enterobacteria, Ontario, Canada. Emerg Infect Dis 2013 0.75
197 Severe acute respiratory syndrome: an update. Curr Opin Infect Dis 2004 0.75
198 In vitro activity of new cephalosporins vs Streptococcus pneumoniae from the Canadian Bacterial Surveillance Network: 2008-2011. Curr Microbiol 2014 0.75
199 Cephalosporin resistance in Neisseria gonorrhoeae infections--reply. JAMA 2013 0.75
200 Facility-level correlates of antimicrobial use in nursing homes. Infect Control Hosp Epidemiol 2004 0.75
201 Serotypes of respiratory tract isolates of Streptococcus pneumoniae from Jamaican children. Int J Infect Dis 2003 0.75
202 Managing acute lower respiratory tract infections in an era of antibacterial resistance. Am J Emerg Med 2006 0.75
203 Chest radiographic manifestations of severe acute respiratory syndrome in health care workers: the Toronto experience. AJR Am J Roentgenol 2004 0.75
204 Successful airway management in a patient with severe proximal achalasia requires interdisciplinary cooperation. A A Case Rep 2014 0.75
205 Interview with Donald E. Low, MD, Microbiologist-in-Chief, Mt. Sinai Hospital, Toronto, Ontario, Canada. Biosecur Bioterror 2004 0.75
206 A chemical approach to the pharmaceutical optimization of an anti-HIV protein. J Am Chem Soc 2007 0.75
207 Infection with H274Y-positive influenza A (H1N1) is not associated with a change in nasopharyngeal Streptococcus pneumoniae colonization in patients. Int J Infect Dis 2009 0.75
208 Identification of sexual networks through molecular typing of quinolone-resistant Neisseria gonorrhoeae in Ontario, Canada. Sex Transm Dis 2011 0.75
209 Development of a molecular-beacon-based multi-allelic real-time RT-PCR assay for the detection of human coronavirus causing severe acute respiratory syndrome (SARS-CoV): a general methodology for detecting rapidly mutating viruses. Arch Virol 2011 0.75